By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Foamix Pharmaceuticals, Ltd. 

2 Holzman Street
Weizmann-Science Park
Rehovot    76704  Israel
Phone: 972-8-9316233 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical






Company News
Foamix Pharmaceuticals, Ltd. (FOMX) Reports Second Quarter 2015 Financial Results And Provides Business Update 8/20/2015 8:11:20 AM
Foamix Pharmaceuticals, Ltd. (FOMX) Second Quarter 2015 Conference Call & Webcast Scheduled For Thursday, August 20 8/13/2015 10:05:32 AM
Bayer HealthCare (BAY) and Foamix Pharmaceuticals, Ltd. (FOMX) Release: Finacea (Azelaic Acid) Foam 15%, Approved By U.S. FDA For Topical Treatment Of The Inflammatory Papules And Pustules Of Mild To Moderate Rosacea 7/31/2015 7:53:51 AM
Foamix Pharmaceuticals, Ltd. (FOMX) Receives Milestone Payment From Merz North America 6/16/2015 7:40:59 AM
Foamix Pharmaceuticals, Ltd. (FOMX) To Present Corporate Overview At The Jefferies and Co. 2015 Global Healthcare Conference 6/1/2015 5:04:52 PM
Foamix Pharmaceuticals, Ltd. (FOMX) Reports First Quarter Financial Results 5/13/2015 10:19:14 AM
Foamix Pharmaceuticals, Ltd. (FOMX) Announces Appointment Of Dr. Aaron Schwartz To Board Of Directors 5/7/2015 7:56:26 AM
Foamix Pharmaceuticals, Ltd. (FOMX) First Quarter 2015 Conference Call & Webcast Scheduled For Wednesday, May 13 4/29/2015 10:59:59 AM
Foamix Pharmaceuticals, Ltd. (FOMX) Announces Closing Of Its $69 Million Public Offering Of Ordinary Shares 4/20/2015 2:24:59 PM
Foamix Pharmaceuticals, Ltd. (FOMX) Announces Upsizing And Pricing Of Its $60 Million Public Offering Of Ordinary Shares 4/15/2015 7:36:50 AM
123456
//-->